The following article, Sato Y, Iwamoto J, Kanoko T, Satoh K. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med. 2005;165(15):1743-1748,1 has been retracted due to acknowledgment of scientific misconduct resulting in concerns about data integrity and inappropriate assignment of authorship.
Corresponding Author: Rita F. Redberg, MD, MSc, University of California, San Francisco, 505 Parnassus Ave, M1180, San Francisco, CA 94143 (firstname.lastname@example.org).
Published Online: June 3, 2016. doi:10.1001/jamainternmed.2016.3771.
Conflict of Interest Disclosures: None reported.
Bauchner H, Redberg RF. Notice of Retraction: Sato Y, et al. Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke. Arch Intern Med. 2005;165(15):1743-1748.. JAMA Intern Med. 2016;176(9):1256. doi:10.1001/jamainternmed.2016.3771